Table 3 Independent association between risk factors (categorical variables) and ESKD and death before ESKD in the entire cohort.

From: Long-term risk for end-stage kidney disease and death in a large population-based cohort

Risk Factor

Categories

ESKD

Death before ESKD

HR (95% CI)

HR (95% CI)

Cases / n

 

353/176,190

21,496/176,190

Obesity

No

1.00

1.00

 

Yes

1.26 (0.97–1.63)

1.10 (1.06–1.14)

Smoking status

Non-smoker

1.00

1.00

 

Smoker

1.50 (1.10–1.71)

1.41 (1.36–1.45)

Diabetes mellitus

No

1.00

1.00

 

Yes

4.62 (3.54–6.03)

1.55 (1.48–1.63)

Hypertension

No

1.00

1.00

 

Yes

2.89 (2.22–3.77)

1.27 (1.23–1.31)

Hypertriglyceridemia

No

1.00

1.00

 

Yes

2.08 (1.32–3.28)

1.10 (0.99–1.23)

Hypercholesterolemia

No

1.00

1.00

 

Yes

1.61 (1.29–2.00)

0.96 (0.93–0.99)

GGT

Normal

1.00

1.00

 

Elevated

1.05 (0.81–1.35)

1.49 (1.44–1.54)

 

(Men: ≥61 U/L

  
 

Women: ≥36 U/L)

  
  1. Categorical data were used. All cause-specific models are fully adjusted. Obesity: BMI ≥30 kg/m2; diabetes mellitus: fasting blood glucose ≥6.9 mmol/L; hypertension: systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg; hypertriglyceridemia: triglycerides ≥2.3 mmol/L; hypercholesterolemia: total cholesterol ≥6.2 mmol/L.
  2. Abbreviations: ESKD, end-stage kidney disease; CI, confidence interval; GGT, γ-glutamyltransferase.
  3. Conversation factor: To convert glucose from mmol/L to mg/dL, multiply by 18.01; triglycerides from mmol/L to mg/dL, multiply by 88.57; cholesterol from mmol/L to mg/dL, multiply by 38.67.